Process Scale Purification of Antibodies | Agenda Bookshop Skip to content
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Uwe Gottschalk
Category1=Non-Fiction
Category=MMG
Category=PSB
Category=TDC
Category=TDCB
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€100 and above
PS=Active
softlaunch

Process Scale Purification of Antibodies

English

Promoting a continued and much-needed renaissance in biopharmaceutical manufacturing, this book covers the different strategies and assembles top-tier technology experts to address the challenges of antibody purification.

    Updates existing topics and adds new ones that include purification of antibodies produced in novel production systems, novel separation technologies, novel antibody formats and alternative scaffolds, and strategies for ton-scale manufacturing
    Presents new and updated discussions of different purification technologies, focusing on how they can address the capacity crunch in antibody purification
    Emphasizes antibodies and innovative chromatography methods for processing See more
Current price €189.99
Original price €199.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Uwe GottschalkCategory1=Non-FictionCategory=MMGCategory=PSBCategory=TDCCategory=TDCBCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 1179g
  • Dimensions: 160 x 239mm
  • Publication Date: 26 May 2017
  • Publisher: John Wiley & Sons Inc
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9781119126911

About

Uwe Gottschalk PhDis Chief Technology Officer at Lonza Pharma/Biotech Switzerland. Previously he served as Group Vice President at Sartorius Stedim Biotech (2004-2014) and in various development and manufacturing capacities at Bayer Health Care (19912004). Dr. Gottschalk received a doctorate in chemistry from the University of Münster (Germany) for work on antibody-drug conjugates at the Cancer Research Campaign Laboratories in Nottingham (UK). He is Head Lecturer at the University of Duisburg-Essen Germany and has written extensively in the areas of industrial biotechnology and somatic gene therapy.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept